Brown Brothers Harriman & Co’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,599
Closed -$195K 1899
2025
Q3
$195K Hold
7,599
﹤0.01% 698
2025
Q2
$192K Buy
+7,599
New +$189K ﹤0.01% 638

Other funds holding IBDX

Brown Brothers Harriman & Co's IBDX Position: Q4 2025 in Review

Brown Brothers Harriman & Co sold out of iShares iBonds Dec 2032 Term Corporate ETF (IBDX) in Q4 2025, closing a stake of 7,599 shares — an estimated $195K sold.

Brown Brothers Harriman & Co first reported a position in IBDX in Q2 2025 and held it in 2 quarters. The position peaked at $195K in Q3 2025. 197 funds tracked by Wall St. Rank hold IBDX as of Q4 2025.

  • Brown Brothers Harriman & Co reported no remaining iShares iBonds Dec 2032 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 7,599 iShares iBonds Dec 2032 Term Corporate ETF shares in Q4 2025, an estimated $195K.
  • Brown Brothers Harriman & Co first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q2 2025 and held it in 2 quarters.
  • Brown Brothers Harriman & Co's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $195K in Q3 2025.
  • 197 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q4 2025.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2025, filed 12 Feb 2026.